Boudjelal Mohamed, Almajed Faisal, Salman Ahmed M, Alharbi Naif K, Colangelo Margaretta, Michelotti Julia M, Olinger Gene, Baker Mariwan, Hill Adrian V S, Alaskar Ahmed
King Abdullah International Medical Research Centre, King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
King Abdullah International Medical Research Centre, King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
Int J Infect Dis. 2021 Apr;105:448-451. doi: 10.1016/j.ijid.2021.02.093. Epub 2021 Feb 27.
The 11th KAIMRC Annual Research Forum Themed "COVID-19 Vaccine: Global Challenges and Prospects Forum" discussed COVID19 Vaccines. The Forum was a vital event as it provided a hub for leading COVID-19 vaccine scientists, regulators, developers, and distributors to learn about COVID-19 vaccines in development, make decisions about the best vaccines to use, and develop appropriate plans for global distribution and pricing. The COVID-19: Global Efforts for Development, Clinical Trials and Distribution Symposium brought together leading scientists, clinicians, pharma, decision makers, academic institutions and businesses to present and discuss the vaccines that are being currently developed for the COVID19. This event was held to shed light on these vaccines as many are at the late stage of Phase III clinical trials and ready to be marketed. This follows the confusion that few vaccines were produced and pushed into phase III without sharing all the necessary data preventing the scientific and clinical community to judge its efficacy and safety. This event allowed a discussion into the challenges in the distribution, pricing and accessibility of the vaccines. Moreover, the symposium discussed the importance to invest in Biotech-Pharma to combat and overcome any future health crisis. The discussion focused on Saudi Arabia leading initiatives as front runner in the field among G20 members.
第十一届沙特国王阿卜杜勒阿齐兹城科学研究中心年度研究论坛以“新冠疫苗:全球挑战与前景论坛”为主题,对新冠疫苗展开了讨论。该论坛是一项重要活动,它为新冠疫苗领域的顶尖科学家、监管机构、研发人员及经销商提供了一个平台,使他们能够了解正在研发的新冠疫苗,决定使用最佳疫苗,并制定全球分发与定价的适当计划。“新冠疫情:全球研发、临床试验及分发努力”研讨会汇聚了顶尖科学家、临床医生、制药企业、决策者、学术机构及企业,以展示并讨论目前正在研发的针对新冠病毒的疫苗。举办此次活动是为了阐明这些疫苗的情况,因为许多疫苗正处于三期临床试验后期并即将上市。此前曾出现混乱局面,少数疫苗在未共享所有必要数据的情况下就进入三期临床试验,这使得科学界和临床界无法评判其疗效和安全性。此次活动对疫苗分发、定价及可及性方面的挑战进行了讨论。此外,研讨会还讨论了投资生物技术制药企业以应对和克服未来任何健康危机的重要性。讨论聚焦于沙特阿拉伯在二十国集团成员中作为该领域领跑者所引领的各项举措。